Bortezomib: a novel therapy approved for multiple myeloma.

Clinical advances in hematology & oncology : H&O

Volumn 1, Issue 10, 2003, Pages 596-600

  Richardson, Paul G ^a   Anderson, Kenneth C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

CHEMISTRY; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MULTIPLE MYELOMA; REVIEW;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CLINICAL TRIALS; HUMANS; MULTIPLE MYELOMA; NF-KAPPA B; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES;

EID: 2342526586     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)